Elisa Vigna

11PUBLICATIONS
54CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Nov 02, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

Federica Galvagno, Valeria Leuci, Annamaria Massa

|Jun 19, 2024
MET Oncogene Targeting for Cancer Immunotherapy.

Andrea Maria Lombardi, Dario Sangiolo, Elisa Vigna

|Jun 22, 2023
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination.

Chiara Modica, Marco Cortese, Francesca Bersani

|Oct 22, 2022
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.

Cristina Chiriaco, Chiara Donini, Marco Cortese

Pageof 2

Frequent Collaborators

6 joint publications

Dario Sangiolo

4 joint publications

Valeria Leuci

4 joint publications

Chiara Donini

4 joint publications

Federica Galvagno